Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity

Cancer Research

Volumn 58, Issue 3, 1998, Pages 402-408

  Yu, Rong ^a   Mandlekar, Sandhya ^a   Harvey, Kevin J ^b   Ucker, David S ^b   Kong, A N Tony ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ISOTHIOCYANIC ACID DERIVATIVE; PHENETHYL ISOTHIOCYANATE; PHENYLBUTYL ISOTHIOCYANATE; PHENYLHEXYL ISOTHIOCYANATE; PHENYLMETHYL ISOTHIOCYANATE; PROTEINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA DEGRADATION; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INDUCTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENZYME INDUCTION; HELA CELLS; HUMANS; ISOTHIOCYANATES; NEOPLASM PROTEINS; OLIGOPEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; THIOCYANATES;

EID: 0032007312     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
2. Steller, H. Mechanisms and genes of cellular suicide. Science (Washington DC), 267: 1445-1449, 1995.
3. Ellis, R. E., Yuan, J-Y., and Horvitz, H. R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol., 7: 663-698, 1991.
4. Ucker, D. S. Death and dying in the immune system. In: S. H. Kaufmann (ed.). Advances in Pharmacology, Vol. 41, pp. 179-218. New York: Academic Press, 1997.
5. Thompson, C. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
6. Laster, S. M., Wood, J. G., and Gooding, L. R. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol., 141: 2629-2634.
7. Nagata, S., and Golstein, P. The Fas death factor. Science (Washington DC) 267: 1449-1456, 1995.
8. Barry, M. A., Behnke, C. A., and Eastman, A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40: 2353-2362, 1990.
9. Buttke, T. M., and Sandstrom, P. A. Oxidative stress as a mediator of apoptosis. Immunol. Today, 15: 7-10, 1994.
10. Miura, M., Zhu, H., Totello, R., Hartwieg, E. A., and Yuan, J-Y. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75: 653-660, 1993.
11. Yuan, J-Y., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell, 75: 641-652, 1993.
12. Alnemri, E. S., Fernandes-Alnemri, T., and Litwack, G. Cloning and expression of four novel isoforms of human interleukin-1β converting enzyme with different apoptotic activities. J. Biol. Chem., 270: 4312-4317, 1995.
13. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
14. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA. 93: 14486-14491, 1996.
15. Faleiro, L., Kobayashi, R., Fearnhead, H., and Lazebnik, Y. Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J., 16: 2271-2281, 1997.
16. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Bauerle, P. A., Droge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K. Requirement of an ICE-like protease in Fas/APO-1-mediated apoptosis. Nature (Lond.), 375: 81-83, 1995.
17. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J-Y. Human ICE/CED-3 protease nomenclature. Cell, 87: 171, 1996.
18. Kostura, M. J., Tocci, M. J., and Limjuxo, G. Identification of a monocyte specific preinterleukin 1β convertase activity. Proc. Natl. Acad. Sci. USA, 86: 5227-5231, 1989.
19. 2 homodimer. Cell, 78: 343-352, 1994.
20. Thornberry, N. A., and Molineaux, S. M. Interleukin-1β converting enzyme: a novel cysieine protease required for IL-1β production and implicated in programmed cell death. Protein Sci., 4: 3-12, 1995.
21. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E., Tracey, D., Wardwell, S., Wel, F-Y., Wong, W., Kamen, R., and Seshadri, T. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell, 80: 401-411, 1995.
22. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. Cpp32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1-convening enzyme. J. Biol. Chem., 269: 30761-30764, 1994.
23. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirer, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32β, a mammalian homolog fo CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
24. Nicholson, D. W., All, A., Thornberry, A. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
25. Casciola-Rosen, L. A., Anhalt, G. J., and Rosen, A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J. Exp. Med., 182: 1625-1634, 1995.
26. Casciola-Rosen, L. A., Miller, D. K., Anhalt, G. J., and Rosen, A. Specific cleavage of 70 kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem., 269: 30757-30760, 1994.
27. Na, S-Q., Chuang, T-H., Cunningham, A., Turi, T. G., Hanke, J. H., Bokoch, G. M., and Danley, D. E. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J. Biol. Chem., 271: 11209-11213, 1996.
28. Datta, R., Kojima, H., Yoshida, K., and Kufe, D. Caspase-3-mediated cleavage of protein kinase C in induction of apoptosis. J. Biol. Chem., 272: 20317-20320, 1997.
29. Liu, X., Zou, H., Slaughter, C., and Wang, X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell, 89: 175-184, 1997.
30. Wattenberg, L. W. Inhibition of carcinogen-induced neoplasia by sodium cyanate, tertbutyl isocyanate, and benzyl isothiocyanates administered subsequent to carcinogen exposure. Cancer Res., 41: 2991-2994, 1981.
31. Stoner, G. D., and Morse, M. A. Isothioyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett., 114: 113-119, 1997.
32. Sones, K., Heaney, R. K., and Fenwick, G. R. A estimate of the main daily intake of glucosinolates from cruciferous vegetables in the U. K. J. Food Agric., 35: 712-720, 1984.
33. 6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res., 49: 2894-2897, 1989.
34. Morse, M. A., Wang, C. X., Stoner, G. D., Mandal, S., Conran, P., Amin, S. G., Hecht, S. S., and Chung, F. L. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced DNA adduct formation and tumorigenicity in lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res., 49: 549-553, 1989.
35. Wattenberg, L. W. Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J. Natl. Cancer Inst. (Bethesda), 58: 385-398, 1977.
36. Smith, T. J., Guo, Z., Li, C., Ning, S. M., Thomas, P. E., and Yang, C. S. Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. Cancer Res., 53: 3276-3282, 1993.
37. Guo, Z., Smith, T. J., Wang, E., Eklind, K., Chung, F. L., and Yang, C. S. Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice. Carcinogenesis (Lond.), 14: 1167-1173, 1993.
38. Zhang, Y., and Talalay, P. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res., 54: (Suppl.): 1976s-1981s, 1994.
39. Thompson, H. J., Jiang, C., Lu, J., Mehta, R. G., Piazza, G. A., Paranka, N. S., Pamukcu, R., and Ahnen, D. J. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res., 57: 267-271, 1997.
40. Tsujii, M., and DuBois, R. N. Alternation in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
41. Harvey, K. J., Blomquist, J. F., and Ucker, D. S. Defining death: commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2, caspase, and cyclin-dependent kinase activities. Mol. Cell. Biol., in press, 1998.
42. Morse, M. A., Eklind, K. I., Amin, S. G., Hecht, S. S., and Chung, F-L. Effect of alkyl chain length on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates. Carcinogenesis (Lond.), 10: 1757-1759, 1989.
43. Morse, M. A., Eklind, K. I., Hecht, S. S., Jordan, K. G., Choi, C. I., Desai, D. H., Amin, S. G., and Chung, F-L. Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNk) lung tumorigenesis by aryalkyl isothiocyanates in A/J mice. Cancer Res., 51: 1846-1850, 1991.
44. Wilkinson, J. T., Morse, M. A., Kresty, L. A., and Stoner, G. D. Effect of alkyl chain length on inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis and DNA methylation by isothiocyanates. Carcinogenesis (Lond.), 16: 1011-1015, 1995.
45. Bruggeman, I. M., Temmink, J. H. M., and Van Blanderen, P. J. Glulathione-and cysteine-mediated cytotoxicity of alkyl and benzyl isothiocyanate. Toxicol. Appl. Pharmacol., 83: 349-359, 1986.
46. Enari, M., Talanian, R. V., Wong, W. W., and Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.), 380: 723-726, 1996.
47. Fernandes-Alnemri, T., Armstrong, R. C., Krebs, J., Srinivasula, S. M., Wang, L., Bullrich, F., Fritz, L. C., Trapani, J. A., Tomaselli, K. J., Litwack, G., and Alnemri, E. S. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FAAD-like domains. Proc. Natl. Acad. Sci. USA, 93: 7464-7469, 1996.
48. Wang, Z-Q., Stingl, L., Morrison, C., Jantsch, M., Los, M., Schulze-Osthoff, K., and Wagner, E. F. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev., 11: 2347-2358, 1997.
49. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Washington DC), 270: 1326-1331, 1995.
50. Verheij, M., Bose, R., Lin, X-H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature (Lond.), 380: 75-79, 1996.
51. Chen, Y. R., Wang, X., Templeton, D., Davis, R. J., and Tan, T-H. The role c-jun-N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J. Biol. Chem., 271: 31929-31936, 1996.
52. 2-terminal kinase-mediated activation of interleukin-1 β converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem., 272: 4631-4636, 1997.
53. Yu, R., Jiao, J-J., Duh, J-L., Tan, T-H., and Kong, A-N. T. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1. Cancer Res., 56: 2954-2959, 1996.